PharmaCyte Biotech
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PMCB and other ETFs, options, and stocks.About PMCB
PharmaCyte Biotech, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of treatments for cancer and diabetes. It focuses on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box, which will be used as a platform for the development of treatments for inoperable pancreatic cancer and other solid cancerous tumors, and diabetes.
PMCB Key Statistics
Stock Snapshot
With a market cap of 3.98M, PharmaCyte Biotech(PMCB) trades at $0.36. The stock has a price-to-earnings ratio of -0.15.
On 2026-11-07, PharmaCyte Biotech(PMCB) stock traded between a low of $0.36 and a high of $0.38. Shares are currently priced at $0.36, which is +0.3% above the low and -5.0% below the high.
PharmaCyte Biotech(PMCB) shares are trading with a volume of 37.5K, against a daily average of 151.61K.
In the last year, PharmaCyte Biotech(PMCB) shares hit a 52-week high of $1.51 and a 52-week low of $0.30.
In the last year, PharmaCyte Biotech(PMCB) shares hit a 52-week high of $1.51 and a 52-week low of $0.30.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.